IFNA2 and Middle East respiratory syndrome: Patients with MERS also had a marked increase in IFN-α2 concentration compared to the healthy controls (P<.01). Patients who were infected had a significant increase in IFN-α2 ranging from 26- to 71-fold increase when compared to healthy controls, indicating a type I IFN response as first line defense against the viral infection [27].